Free Trial

Medifast (MED) Earnings Date, Estimates & Call Transcripts

Medifast logo
$13.01 -0.09 (-0.69%)
Closing price 05/6/2025 03:59 PM Eastern
Extended Trading
$13.01 0.00 (0.00%)
As of 05/6/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medifast Earnings Summary

Latest Q1
Earnings Date
Apr. 28Estimated
Consensus EPS
(Apr. 28)
-$0.07
Actual EPS
(Apr. 28)
-$0.11 Missed By -$0.04
Actual Revenue
(Apr. 28)
$115.73M

Medifast issued Q1 2025 earnings on April 28, 2025, reporting an EPS of -$0.11, which missed the consensus estimate of -$0.07 by $0.04. Quarterly revenue was reported to be $115.73 million, above analyst estimates of $114.85 million. With a trailing EPS of -$0.65 and a P/E Ratio of 72.28, Medifast's earnings are expected to grow 200.00% next year, from $0.51 to $1.53 per share.

Q1 2025 Earnings Resources

Get Medifast Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medifast and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MED Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MED Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Medifast Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20252-$0.32-$0.07-$0.20$130.8 M - 0.500 - 0.000$100.0 M - $120.0 M
Q2 20251$0.24$0.24$0.24$112.3 M - 0.550 - 0.000$85.0 M - $105.0 M
Q3 20251$0.33$0.33$0.33
Q4 20251$0.53$0.53$0.53
FY 2025 5 $0.78 $1.03 $0.91
Q1 20261$0.32$0.32$0.32
Q2 20261$0.32$0.32$0.32
Q3 20261$0.39$0.39$0.39
Q4 20261$0.49$0.49$0.49

Medifast Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/28/2025Q1 2025-$0.07-$0.11 -$0.04-$0.07$114.85M$115.73M
2/18/2025Q4 2024-$0.16$0.10+$0.26$0.08$114.25M$119.00M
11/4/2024Q3 2024-$0.15$0.35+$0.50$0.60$135.45M$140.16M
8/5/2024Q2 2024$0.36$0.92+$0.56$2.59$160.44M$168.56M
4/29/2024Q1 2024$0.78$0.66 -$0.12$0.56$168.90M$174.74M
2/20/2024Q4 2023$0.99$1.09+$0.10$1.63$184.17M$191.02M
11/6/2023Q3 2023$1.02$2.12+$1.10$2.12$232.10M$235.87M
8/7/2023Q2 2023$1.44$2.77+$1.33$2.77$270.20M$296.20M

Medifast Earnings - Frequently Asked Questions

Medifast (NYSE:MED) last announced its quarterly earning data on Monday, April 28, 2025. Learn more on MED's earnings history.

Medifast updated its second quarter 2025 earnings guidance on Monday, April, 28th. The company provided EPS guidance of -0.550-0.000 for the period, compared to the consensus earnings per share estimate of -0.070. The company issued revenue guidance of $85.0 million-$105.0 million, compared to the consensus revenue estimate of $112.3 million.

In the previous quarter, Medifast (NYSE:MED) missed the analysts' consensus estimate of ($0.07) by $0.04 with a reported earnings per share (EPS) of ($0.11). Learn more on analysts' earnings estimate vs. MED's actual earnings.

The conference call for Medifast's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Medifast's latest earnings report can be read online.
Read Transcript

Medifast (NYSE:MED) has a recorded annual revenue of $543.45 million.

Medifast (NYSE:MED) has a recorded net income of $99.42 million. MED has generated -$0.65 earnings per share over the last four quarters.

Medifast (NYSE:MED) has a trailing price-to-earnings ratio of 72.28 and a forward price-to-earnings ratio of 25.51.

Medifast's earnings are expected to grow from $0.51 per share to $1.53 per share in the next year, which is a 200.00% increase.

More Earnings Resources from MarketBeat



This page (NYSE:MED) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners